Department of Child Health Care, Children's Hospital, Fudan University
Shanghai, China
NCT Number: NCT01755481
To evaluate the effects of feeding an infant formula containing L. paracasei ssp. paracasei strain F19 or Whey Protein Concentrate.
Looking for future studies?
Notify MeUp to 2 week
All sexes
Interventional
Not applicable
Shanghai, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(formula-fed group):
healthy infants of mothers who could not or voluntarily resigned completely from breast-feeding at infant age 14 plus/minus 3 days
Inclusion criteria
(breast-fed group):
healthy infants exclusively breast-fed from birth and mothers intending to breastfeed >80% until at least 5th month of age (meaning through the 4th month of age).
Inclusion criteria
(all infants):
delivered between 37 and 42 weeks of gestation birth weight >2500 g and <4000 g parent or the subject's legal representative speak and understand Chinese
Exclusion criteria
(formula-fed group):
fully or partially breast-fed infants infants breast-fed >20%
Exclusion criteria
(breast-fed group):
infants fed >20% infant formula
Exclusion criteria
(all infants):
malformations, handicaps or congenital diseases that could affect normal feeding or growth treatment with antibiotics
Time frame: 4 yrs
Arla Foods
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06594900
Focus on Healthy Infants
Basel, Basellandschaft, Switzerland
View Trial Details